Overview
- 78 inspections across 77 sites are on record.
- 129 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2010-12-07.
At a glance
Inspections
78
Sites
77
Observations
129
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| American Diagnostic Corporation | 7 Dec 2010 | ||
| Leonid Zaslavsky, M.D. | 15 Oct 2010 | ||
| Larysa Dudar, M.d. | 8 Oct 2010 | ||
| Danbury Pharma, LLC | 9 Sep 2010 | View 483 → | |
| Venus Pharmaceuticals International, Inc. | 19 Aug 2010 | View 483 → |
Sites inspected
American Diagnostic CorporationHauppauge, United States1 insp.
Leonid Zaslavsky, M.D.St. Petersburg, Russia1 insp.
Larysa Dudar, M.d.Kyiv, Ukraine1 insp.
Danbury Pharma, LLCFarmingdale, United States1 insp.
Venus Pharmaceuticals International, Inc.Hauppauge, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Irina Gaberman9 shared
Meredith P Soehl5 shared
Ronald Ifraimov3 shared
Iram R Hassan3 shared
Shreya Shah2 shared
Neil J Bonzagni2 shared
Matthew R Palo2 shared
Thomas P Hansen2 shared
Amber D Brodas1 shared
Frank Verni1 shared
Full investigator report
Get the verbatim findings behind Stephanie Durso's 129 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site